A Study of NX-1607 in Adults With Advanced Malignancies
מצבים רפואיים
Ovarian Cancer, Epithelial · Gastric Cancer · GastroEsophageal Junction (GEJ) Cancer · Head and Neck Squamous Cell Carcinoma · Metastatic or Unresectable Melanoma · Non-small Cell Lung Cancer (NSCLC) · Metastatic Castration-resistant Prostate Cancer (mCRPC) · Malignant Pleural Mesothelioma (MPM) · Triple Negative Breast Cancer (TNBC) · Metastatic Urothelial Carcinoma · Cervical Cancer · Diffuse Large B Cell Lymphoma (DLBCL) · Richter Transformation · Microsatellite Stable Colorectal Carcinoma
סיכום בשפה פשוטהבעזרת בינה מלאכותית
הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.
מיקומים
City of Hope, Duarte, California, United States
University of Southern California, Los Angeles, California, United States
University of California, San Francisco, San Francisco, California, United States
University of Colorado School of Medicine, Aurora, Colorado, United States
Contact: Study coordinator (Brandi Asheim)Contact: Principal Investigator (Wells Messersmith, MD)University of Chicago, Chicago, Illinois, United States
University of North Carolina, Chapel Hill, North Carolina, United States
Contact: Study coordinator (Clinical Trials Office) · cancerclinicaltrials@med.unc.edu · 919-966-4432University of Oklahoma, Oklahoma City, Oklahoma, United States
Contact: Study coordinator (Christina Caldwell)MD Anderson Cancer Center, Houston, Texas, United States
University of Virginia, Charlottesville, Virginia, United States
Fred Hutchinson Cancer Center, Seattle, Washington, United States
Royal Marsden Hospital NHS Foundation Trust, Sutton, Surrey, United Kingdom
Addenbrookes Cambridge University Hospital, Cambridge, United Kingdom
Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom
Contact: Study coordinator (Ruth Orr)Sarah Cannon Research Institute, London, United Kingdom
The Christie NHS Foundation Trust, Manchester, United Kingdom
Contact: Study coordinator (The Christie Enquiries)Northern Centre for Cancer Care, Newcastle, United Kingdom
Churchill Hospital, Oxford, United Kingdom
מובילי המחקר
Linda Neuman, MD
Study Director
Nurix Therapeutics, Inc.